Sutro Biopharma Inc reports results for the quarter ended in March - Earnings Summary

Sutro Biopharma

09/05/2022 23:37

* Sutro Biopharma Inc  STRO.OQ  reported a quarterly
adjusted loss
of 84 cents​​ per share for the quarter ended in March. The mean
expectation of eight analysts for the quarter was for a loss
of 76 cents per share.
    * Revenue fell 59.8% to $5.90 million from a year ago; 
analysts
expected $10.47 million. 
    * Sutro Biopharma Inc's reported EPS for the quarter was a
loss
of 84 cents​.
    * The mean earnings estimate of analysts had fallen by
about 5% in
the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Sutro Biopharma Inc shares had fallen by 30.4% this
quarter and
lost 61.6% so far this year.
    * The company reported a quarterly loss of $39.11 million.
    * Wall Street's median 12-month price target for Sutro
Biopharma
Inc is $30.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 9 at 10:37 p.m.  ​All
figures in US dollars unless otherwise stated